Business Responsibility and Sustainability Report for FY25

Granules India has filed its annual BRSR for FY25 as required by SEBI regulations. The pharmaceutical company (exports contribute 92.38% of revenue, ₹30,302 million) highlighted key sustainability milestones including SBTi-approved Net Zero target by 2050, a two-level improvement to 'B' rating in CDP Climate assessment, and an EcoVadis Gold rating placing it in the top 5% globally (97th percentile, score 79/100). On the environmental front, the company reduced Scope 1+2 emissions by 32.2% since FY23 base year, sourced 68.7% of electricity and 24.2% of total energy from renewables, recycled 44.2% of wastewater, and sent 80% of hazardous waste for co-processing. On the social front, the company reported zero workplace fatalities, 31.6% reduction in recorded incidents, 100% employee health coverage, and CSR programs touching thousands of beneficiaries. The report was assured by Bureau Veritas with reasonable assurance for BRSR Core.